These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
72 related articles for article (PubMed ID: 8095250)
1. The onset of action of formoterol, a new beta 2 adrenoceptor agonist. Stam J; Souren M; Zweers P Int J Clin Pharmacol Ther Toxicol; 1993 Jan; 31(1):23-6. PubMed ID: 8095250 [TBL] [Abstract][Full Text] [Related]
2. Beta2-adrenoceptor regulation and bronchodilator sensitivity after regular treatment with formoterol in subjects with stable asthma. Aziz I; Hall IP; McFarlane LC; Lipworth BJ J Allergy Clin Immunol; 1998 Mar; 101(3):337-41. PubMed ID: 9525449 [TBL] [Abstract][Full Text] [Related]
3. Fast onset of effect of budesonide/formoterol versus salmeterol/fluticasone and salbutamol in patients with chronic obstructive pulmonary disease and reversible airway obstruction. Lindberg A; Szalai Z; Pullerits T; Radeczky E Respirology; 2007 Sep; 12(5):732-9. PubMed ID: 17875063 [TBL] [Abstract][Full Text] [Related]
4. The duration of action of inhaled formoterol dry powder. Quebe-Fehling E; Brambilla R; Bromly CL; Fishwick K; Walters EH; Hendrick DJ Br J Clin Pract; 1996 Dec; 50(8):446-9. PubMed ID: 9039716 [TBL] [Abstract][Full Text] [Related]
5. Beta2-adrenoceptor polymorphism and bronchoprotective sensitivity with regular short- and long-acting beta2-agonist therapy. Lipworth BJ; Hall IP; Aziz I; Tan KS; Wheatley A Clin Sci (Lond); 1999 Mar; 96(3):253-9. PubMed ID: 10029561 [TBL] [Abstract][Full Text] [Related]
6. Two oral beta-adrenergic stimulant drugs, pirbuterol and salbutamol, in reversible airway obstruction. Dyson AJ; Mackay AD Br J Dis Chest; 1980 Jan; 74(1):70-7. PubMed ID: 6101961 [TBL] [Abstract][Full Text] [Related]
7. Time course of bronchodilating effect of inhaled formoterol, a potent and long acting sympathomimetic. Derom EY; Pauwels RA Thorax; 1992 Jan; 47(1):30-3. PubMed ID: 1539141 [TBL] [Abstract][Full Text] [Related]
8. Long-term effects of formoterol and salbutamol on bronchial hyperreactivity and beta-adrenoceptor density on lymphocytes in children with bronchial asthma. Kozlik-Feldmann R; von Berg A; Berdel D; Reinhardt D Eur J Med Res; 1996 Jul; 1(10):465-70. PubMed ID: 9438143 [TBL] [Abstract][Full Text] [Related]
9. [The effect of a single dose of formoterol using an aerosol inhaler in asthmatic children. A randomized, controlled, double-blind study]. Lebecque P; Vliers S; De Saint-Moulin T; Godding V Rev Mal Respir; 1994; 11(1):47-50. PubMed ID: 7907426 [TBL] [Abstract][Full Text] [Related]
10. [Effect of the long-acting beta-2 agonist inhalant formoterol on the quality of sleep of patients with bronchial asthma]. Konermann M; Lück G; Rawert B; Pirsig W Pneumologie; 2000 Mar; 54(3):104-9. PubMed ID: 10783649 [TBL] [Abstract][Full Text] [Related]
11. Formoterol for maintenance and as-needed treatment of chronic obstructive pulmonary disease. Campbell M; Eliraz A; Johansson G; Tornling G; Nihlén U; Bengtsson T; Rabe KF Respir Med; 2005 Dec; 99(12):1511-20. PubMed ID: 16199148 [TBL] [Abstract][Full Text] [Related]
12. [Bronchial asthma treated with long-acting beta 2 agonist. Comparison between formoterol (12 mu/g) inhaled twice daily and salbutamol (200 mu/g) inhaled 4 times daily]. Sprogøe-Jakobsen U; Viktrup L; Davidsen O; Viskum K Ugeskr Laeger; 1992 Nov; 154(47):3325-8. PubMed ID: 1361083 [TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of formoterol for the treatment of chronic obstructive pulmonary disease. Berger WE; Nadel JA Respir Med; 2008 Feb; 102(2):173-88. PubMed ID: 18023995 [TBL] [Abstract][Full Text] [Related]
14. Efficacy of inhaled formoterol in reversing bronchoconstriction. Rubin AS; Perin C; Pelegrin L; Fernandes JC; da Silva LC J Bras Pneumol; 2006; 32(3):202-6. PubMed ID: 17273608 [TBL] [Abstract][Full Text] [Related]
15. Inhaled formoterol during one year in asthma: a comparison with salbutamol. Arvidsson P; Larsson S; Löfdahl CG; Melander B; Svedmyr N; Wåhlander L Eur Respir J; 1991 Nov; 4(10):1168-73. PubMed ID: 1687129 [TBL] [Abstract][Full Text] [Related]
16. Cross tolerance to salbutamol occurs independently of beta2 adrenoceptor genotype-16 in asthmatic patients receiving regular formoterol or salmeterol. Lee DK; Jackson CM; Bates CE; Lipworth BJ Thorax; 2004 Aug; 59(8):662-7. PubMed ID: 15282385 [TBL] [Abstract][Full Text] [Related]
17. Effect of inhaled formoterol and budesonide on exacerbations of asthma. Formoterol and Corticosteroids Establishing Therapy (FACET) International Study Group. Pauwels RA; Löfdahl CG; Postma DS; Tattersfield AE; O'Byrne P; Barnes PJ; Ullman A N Engl J Med; 1997 Nov; 337(20):1405-11. PubMed ID: 9358137 [TBL] [Abstract][Full Text] [Related]
18. Formoterol by pressurized metered-dose aerosol or dry powder on airway obstruction and lung hyperinflation in partially reversible COPD. Brusasco V; Canonica GW; Dal Negro R; Scano G; Paggiaro P; Fabbri LM; Barisione G; D'Amato G; Varoli G; Baroffio M; Milanese M; Mereu C; Crimi E J Aerosol Med Pulm Drug Deliv; 2011 Oct; 24(5):235-43. PubMed ID: 21689019 [TBL] [Abstract][Full Text] [Related]